直觉外科公司公布2025年第四季度业绩，营收为28.7亿美元，同比增长19%，高于分析师预期的27.5亿美元；调整后每股收益为2.53美元，亦高于分析师预期的2.26美元。期内，手术量(包括达芬奇手术系统与伊翁手术系统)同比增长约18%。展望2026年，该公司预计全球达芬奇辅助手术将增长13%至15%，对比2025年增长18%。
直觉外科公司公布2025年第四季度业绩，营收为28.7亿美元，同比增长19%，高于分析师预期的27.5亿美元；调整后每股收益为2.53美元，亦高于分析师预期的2.26美元。期内，手术量(包括达芬奇手术系统与伊翁手术系统)同比增长约18%。展望2026年，该公司预计全球达芬奇辅助手术将增长13%至15%，对比2025年增长18%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.